Freestone Grove Partners’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-2,528
Closed -$574K – 863
2025
Q3
$574K Sell
2,528
-3,422
-58% -$701K ﹤0.01% 515
2025
Q2
$1.24M Sell
5,950
-311
-5% -$59.9K 0.01% 414
2025
Q1
$1.22M Buy
6,261
+5,051
+417% +$1.04M 0.01% 336
2024
Q4
$273K Buy
+1,210
New +$270K ﹤0.01% 486

Other funds holding MSGS

Freestone Grove Partners's MSGS Position: Q4 2025 in Review

Freestone Grove Partners sold out of Madison Square Garden (MSGS) in Q4 2025, closing a stake of 2,528 shares — an estimated $574K sold.

Freestone Grove Partners first reported a position in MSGS in Q4 2024 and held it in 4 quarters. The position peaked at $1.24M in Q2 2025. 380 funds tracked by Wall St. Rank hold MSGS as of Q4 2025.

  • Freestone Grove Partners reported no remaining Madison Square Garden position as of Q4 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 2,528 Madison Square Garden shares in Q4 2025, an estimated $574K.
  • Freestone Grove Partners first reported a position in Madison Square Garden in Q4 2024 and held it in 4 quarters.
  • Freestone Grove Partners's Madison Square Garden position peaked at $1.24M in Q2 2025.
  • 380 funds tracked by Wall St. Rank held Madison Square Garden as of Q4 2025.

Based on Freestone Grove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.